Moreover, under drug‐mediated pressure, NF‐κB might cooperate with other signaling pathways to regulate pro‐survival genes (such as cyclin D1 and Bcl‐2) and upregulate the transcription of the genes, which helps tumor cells to develop drug resistance. This evidence concerns the gene NFKB1 and neoplasm.